Germany

 

Healthcare Activos raises new fund worth €650m

Pan-European Spanish healthcare real estate investor Healthcare Activos has launched a new investment fund worth €650 million. This is the REIT’s second fund, and will, in contrast to the first fund, be primarily focused on making investments outside of Spain and Portugal. Jorge Guarner, Activos’ President and Founder, tells us more.

Will Germany’s hospital reform fix the sector’s problems?

Two weeks ago Germany’s cabinet government approved Health Minister Karl Lauterbach’s hospital reform. The current watered-down reform’s key feature is a proposal to move the sector’s reimbursement model away from fee-per-service payments, purportedly to reduce the incentive to overtreat. However, experts tell us the real motivation is still to shut down smaller unspecialised hospitals. Will it succeed in doing so?

Interview: Dr. Volker Wendel, Sanoptis

Dr. Volker Wendel founded Sanoptis in 2018 in Switzerland with Carsten Horn. Six years later, the group has grown to more than 400 locations across six European countries. The group was initially backed by PE firm Telemos Capital, who then sold it to Belgian holding company Group Bruxelles Lambert (in 2022). Wendel explains to us how the group is able to add value to ophthalmologists who join the network and shares which areas the group will be focusing on in the coming years.

Lauterbach’s German hospital reform set to launch

Germany’s cabinet government has approved Health Minister Karl Lauterbach’s controversial hospital reform. The draft law will now go to the Bundestag, where it is likely to pass. After several months of political wrangling, the final version is focused on moving hospital financing away from DRG-based fee-per-service payments. 

PAI Partners to acquire Vamed rehab clinics

French PE firm PAI Partners will become the new owner of Fresenius Vamed’s rehab business. Vamed is currently a subsidiary of German health care conglomerate Fresenius, who will continue to hold a minority stake.

UK ophtha market heating up, whilst Germany’s remains cool

The UK’s for-profit ophthalmology sector is heating up, with multiple groups likely to come up for sale this year. This is being driven by the long term increase in the amount of cataract surgeries the NHS is outsourcing. Meanwhile deal activity in Germany’s sector is still on pause, due to a decrease in cataract surgery post Covid.

Find Us